Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Extracellular Matrix in Mice Lacking Thrombospondin 2
Acamprosate and Group-I Metabotropic Glutamate Receptors
Molecular Mechanisms Cytokine Receptor Signaling
Graduate Training in Cognitive and Biological Psychology
Action of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
Recently added grants:
Dissecting Mechanisms of Granuloma Macrophage Polarization and Granuloma Formation in Chronic Salmonella Infection
Defining the ecology of tick-borne relapsing fever Borrelia turicatae in Austin, Texas.
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
Novel lung resident interstitial macrophage subset with distinct localization and polarization
Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signaling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07155-16-0-1
Application #
7574917
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ St. Jude Children's Research Hospital
$456,619
NIH 2007
N01 HL
Pedriatric Hydroxyurea Phase III Clinical Trial Clinical
Wang, Winfred C. /
$496,007
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant